» Articles » PMID: 25552918

Astrocytes Protect Neurons from Aβ1-42 Peptide-induced Neurotoxicity Increasing TFAM and PGC-1 and Decreasing PPAR-γ and SIRT-1

Overview
Journal Int J Med Sci
Specialty General Medicine
Date 2015 Jan 2
PMID 25552918
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

One of the earliest neuropathological events in Alzheimer's disease is accumulation of astrocytes at sites of Aβ1-42 depositions. Our results indicate that Aβ1-42 toxic peptide increases lipid peroxidation, apoptosis and cell death in neurons but not in astrocytes in primary culture. Aβ1-42-induced deleterious neuronal effects are not present when neurons and astrocytes are mixed cultured. Stimulation of astrocytes with toxic Aβ1-42 peptide increased p-65 and decreased IκB resulting in inflammatory process. In astrocytes Aβ1-42 decreases protein expressions of sirtuin 1 (SIRT-1) and peroxisome proliferator-activated receptor γ (PPAR-γ) and over-expresses peroxisome proliferator-activated receptor γ coactivator 1 (PGC-1) and mitochondrial transcription factor A (TFAM), protecting mitochondria against Aβ1-42-induced damage and promoting mitochondrial biogenesis. In summary our data suggest that astrocytes may have a key role in protecting neurons, increasing neural viability and mitochondrial biogenesis, acquiring better oxidative stress protection and perhaps modulating inflammatory processes against Aβ1-42 toxic peptide. This might be a sign of a complex epigenetic process in Alzheimer's disease development.

Citing Articles

Exploring fatty acid metabolism in Alzheimer's disease: the key role of CPT1A.

Ju Y, Li S, Kong X, Zhao Q Sci Rep. 2024; 14(1):31483.

PMID: 39733087 PMC: 11682225. DOI: 10.1038/s41598-024-82999-z.


Different amyloid β42 preparations induce different cell death pathways in the model of SH-SY5Y neuroblastoma cells.

Ozdemir A, Hofbauerova K, Kopecky Jr V, Novotny J, Rudajev V Cell Mol Biol Lett. 2024; 29(1):143.

PMID: 39551742 PMC: 11572474. DOI: 10.1186/s11658-024-00657-8.


Research progress of SREBP and its role in the pathogenesis of autoimmune rheumatic diseases.

Xu X, Jin W, Chang R, Ding X Front Immunol. 2024; 15:1398921.

PMID: 39224584 PMC: 11366632. DOI: 10.3389/fimmu.2024.1398921.


Tryptophan Metabolism in Alzheimer's Disease with the Involvement of Microglia and Astrocyte Crosstalk and Gut-Brain Axis.

Xie L, Wu Q, Li K, Khan M, Zhang A, Sinha B Aging Dis. 2024; 15(5):2168-2190.

PMID: 38916729 PMC: 11346405. DOI: 10.14336/AD.2024.0134.


Glioprotective Effects of Sulforaphane in Hypothalamus: Focus on Aging Brain.

Santos C, Weber F, Bello-Klein A, Bobermin L, Quincozes-Santos A Neurochem Res. 2024; 49(9):2505-2518.

PMID: 38886329 DOI: 10.1007/s11064-024-04196-8.


References
1.
Kang C, Ji L . Role of PGC-1α signaling in skeletal muscle health and disease. Ann N Y Acad Sci. 2012; 1271:110-7. PMC: 3499658. DOI: 10.1111/j.1749-6632.2012.06738.x. View

2.
Reddy P, Beal M . Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease. Trends Mol Med. 2008; 14(2):45-53. PMC: 3107703. DOI: 10.1016/j.molmed.2007.12.002. View

3.
Ikeuchi M, Matsusaka H, Kang D, Matsushima S, Ide T, Kubota T . Overexpression of mitochondrial transcription factor a ameliorates mitochondrial deficiencies and cardiac failure after myocardial infarction. Circulation. 2005; 112(5):683-90. DOI: 10.1161/CIRCULATIONAHA.104.524835. View

4.
Pappolla M, Chyan Y, Poeggeler B, Bozner P, Ghiso J, LeDoux S . Alzheimer beta protein mediated oxidative damage of mitochondrial DNA: prevention by melatonin. J Pineal Res. 1999; 27(4):226-9. DOI: 10.1111/j.1600-079x.1999.tb00619.x. View

5.
Trushina E, McMurray C . Oxidative stress and mitochondrial dysfunction in neurodegenerative diseases. Neuroscience. 2007; 145(4):1233-48. DOI: 10.1016/j.neuroscience.2006.10.056. View